Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Switchenko

Showing results (51-60 of 181) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|August 8, 2017
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemiaVishal Dhere, Scott Edelman, Edmund K Waller, et al.
Cancer Epidemiology|March 8, 2016
Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphomaJeffrey M Switchenko, Catherine Bulka, Kevin Ward, et al.
Melanoma Research|May 26, 2016
BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosisKirtesh R Patel, Mudit Chowdhary, Jeffrey M Switchenko, et al.
Cancer|February 1, 2017
Discussing molecular testing in oncology care: Comparing patient and physician information preferencesAna P M Pinheiro, Rachel H Pocock, Jeffrey M Switchenko, et al.
JAMA Network Open|January 11, 2022
Race, Ethnicity, and Sex Among Senior Faculty in Radiation Oncology From 2000 to 2019James R Janopaul-Naylor, Sanford E Roberts, Hui-Kuo Shu, et al.
Journal of the American College of Radiology : JACR|July 24, 2025
Patient Reminders and Self-Referrals via Online Patient Portals and Text Messaging to Improve Adherence to Screening Mammography: A Randomized Controlled TrialPatricia Balthazar, Ilana Graetz, Jeffrey M Switchenko, et al.
Cancer|July 22, 2022
Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortalityLeah Moubadder, Lindsay J Collin, Rebecca Nash, et al.
JCO Oncology Practice|July 8, 2026
Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine NeoplasmsJennifer W Carlisle, Katherine O'Reilly, Xiyuan Angel Ji, et al.
Leukemia & Lymphoma|August 12, 2017
Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utilityDaniel M Guidot, Jeffrey M Switchenko, Loretta J Nastoupil, et al.
Radiation Oncology (London, England)|September 16, 2020
Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancerSagar A Patel, Jeffrey M Switchenko, Ben Fischer-Valuck, et al.
Pageof 19

Showing results (51-60 of 181) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|August 8, 2017
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemiaVishal Dhere, Scott Edelman, Edmund K Waller, et al.
Cancer Epidemiology|March 8, 2016
Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphomaJeffrey M Switchenko, Catherine Bulka, Kevin Ward, et al.
Melanoma Research|May 26, 2016
BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosisKirtesh R Patel, Mudit Chowdhary, Jeffrey M Switchenko, et al.
Cancer|February 1, 2017
Discussing molecular testing in oncology care: Comparing patient and physician information preferencesAna P M Pinheiro, Rachel H Pocock, Jeffrey M Switchenko, et al.
JAMA Network Open|January 11, 2022
Race, Ethnicity, and Sex Among Senior Faculty in Radiation Oncology From 2000 to 2019James R Janopaul-Naylor, Sanford E Roberts, Hui-Kuo Shu, et al.
Journal of the American College of Radiology : JACR|July 24, 2025
Patient Reminders and Self-Referrals via Online Patient Portals and Text Messaging to Improve Adherence to Screening Mammography: A Randomized Controlled TrialPatricia Balthazar, Ilana Graetz, Jeffrey M Switchenko, et al.
Cancer|July 22, 2022
Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortalityLeah Moubadder, Lindsay J Collin, Rebecca Nash, et al.
JCO Oncology Practice|July 8, 2026
Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine NeoplasmsJennifer W Carlisle, Katherine O'Reilly, Xiyuan Angel Ji, et al.
Leukemia & Lymphoma|August 12, 2017
Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utilityDaniel M Guidot, Jeffrey M Switchenko, Loretta J Nastoupil, et al.
Radiation Oncology (London, England)|September 16, 2020
Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancerSagar A Patel, Jeffrey M Switchenko, Ben Fischer-Valuck, et al.
Pageof 19